CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Lake Mary, Florida, United States and 61 other locations
of this study is to evaluate the safety and preliminary efficacy of ATA3219 in participants with relapsed/refractory (R/R) B-cell non-Hodgkin Lymphoma...
Phase 1
Orlando, Florida, United States and 2 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Orlando, Florida, United States and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Orange City, Florida, United States and 94 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Orlando, Florida, United States and 73 other locations
or obinutuzumab) in subjects with relapsed or refractory (R/R) lymphoma. Subjects must have received at least 2 prior lines of therapy, and ...
Phase 1
Lake Mary, Florida, United States and 25 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:* Find the recommended dose...
Phase 1, Phase 2
Orlando, Florida, United States and 9 other locations
patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas who have failed or a...
Phase 1
Orlando, Florida, United States and 29 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Orlando, Florida, United States and 33 other locations
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Orlando, Florida, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal